Back to VIR
GOLDMAN SACHS GROUP INC VIR Position History
Vir Biotechnology, Inc. • Healthcare
Quarters held
15
Latest value
$124K
Q3 2026
Peak value
$28M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $6.2M |
| Q2 2025 | $280K |
| Q3 2025 | $8.4M |
| Q3 2025 | $299K |
| Q4 2025 | $437K |
| Q4 2025 | $9M |
| Q4 2025 | $9M |
| Q4 2025 | $437K |
| Q1 2026 | $28M |
| Q1 2026 | $1.1M |
| Q2 2026 | $22.2M |
| Q2 2026 | $1.9M |
| Q3 2026 | $2M |
| Q3 2026 | $7.3M |
| Q3 2026 | $124K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $124K | 11.1K | — | — |
| Q3 2026 | $7.3M | 654.9K | — | — |
| Q3 2026 | $2M | 180.6K | — | — |
| Q2 2026 | $1.9M | 186.0K | — | — |
| Q2 2026 | $22.2M | 2.18M | — | — |
| Q1 2026 | $1.1M | 126.6K | — | — |
| Q1 2026 | $28M | 3.12M | — | — |
| Q4 2025 | $437K | 72.5K | — | — |
| Q4 2025 | $9M | 1.50M | — | — |
| Q4 2025 | $9M | 1.50M | — | — |
| Q4 2025 | $437K | 72.5K | — | — |
| Q3 2025 | $299K | 52.4K | — | — |
| Q3 2025 | $8.4M | 1.47M | — | — |
| Q2 2025 | $280K | 55.5K | — | — |
| Q2 2025 | $6.2M | 1.23M | — | — |